StockData
QTREX Quantum Ltd. logo

QTREX Quantum Ltd. (QTEX) company profile

QTEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 5/30
$1.09−0.06 (-5.22%)

Close on Nov 17, 2026Market cap $39.18MP/E –Yield –

About QTREX Quantum

Surgical & Medical Instruments & Apparatus, SIC 3841

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company that develops, manufactures, and commercializes proprietary life-support technologies. Its development efforts target acute respiratory failure solutions designed to offer alternatives or complementary options to traditional mechanical ventilation by enabling spontaneous breathing and reducing the need for invasive intubation or medically induced comas. The company's pipeline includes the flagship INSPIRA ART platform for extracorporeal blood oxygenation and monitoring, the FDA-cleared INSPIRA ART100 cardiopulmonary bypass system for surgical procedures, and the HYLA blood sensor for continuous real-time blood parameter analysis. The company targets healthcare providers across intensive care units, general medical units, operating theaters, and emergency settings.

The company operates its corporate headquarters and principal executive offices in Ra'anana, Israel. Its commercial reach and clinical collaborations include agreements with distributors and deployments to medical centers, such as Westchester Medical Center in New York. Inspira Technologies focuses its deployment strategy across regional health centers, intensive care units, and small urban and rural hospitals.

Summary of the business section of QTREX Quantum's latest annual report, written by StockData.

Company profile

Company

Legal name
QTREX Quantum Ltd.
Founded
2018
Headquarters
Ra'Anana, Israel
Address
Hatidhar 2, 11th Floor
Phone
972-9-9664488
Employees
30, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
L3
Fiscal year ends
December 31
Auditor
Ziv Haft, Tel-Aviv, Israel

Stock & identifiers

Ticker
QTEX
Former tickers
IINN until Mar 26, 2026
Exchange
Nasdaq
IPO date
Jul 15, 2021
Shares outstanding
36M, Dec 31, 2025
Filer category
Non-accelerated filer<br>Emerging growth company
SEC CIK
1837493
CUSIP
M53637100
FIGI
BBG00ZKH0PK4
Share class FIGI
BBG00ZKH0QD0
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Dagi Shahar Ben-NoonChief Executive Officer, Director3,678,407
abraham shabtayCOO1,882,713
Yafit TehilaChief Financial Officer1,420,000
Hayon Daniella YechezkelyChief Technology Officer1,330,000
Yoav RozanovichChief Business Officer550,000
Tal ParnesDirector766,666
Sivan MatzaDirector130,000
Lior AmitDirector231,667
Shlomit Chappel-RamDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jul 15, 2021
Offer price
$5.51
Securities offered
2,909,091
Gross proceeds
$16.03M
Exchange
Nasdaq
First trading day
Jul 14, 2021
First-day close
$4.75-13.8%
Lock-up ends (est.)
Jan 10, 2022

“The initial public offering price per Unit is $5.51, and the exercise price of each Warrant included in the Unit is $5.50 per Ordinary Share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“of 30 people as of December 31, 2025.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jul 15, 2026DelistingNotice of delisting from exchange (Form 25)
May 19, 2026Name changeName changed from Inspira Technologies OXY B.H.N. Ltd to QTREX Quantum Ltd.
Jul 15, 2021IPOInitial public offering priced (424B4 prospectus)
Mar 30, 2021ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?